ResearchEpitope Expression Persists in Circulating Tumor Cells as Breast Cancers Acquire Resistance to Antibody Drug Conjugates
ResearchGenomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes
ResearchCirculating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR+/HER2- metastatic breast cancer: a retrospective multi-institutional Consortium analysis
ResearchNovel oral selective estrogen receptor degraders (SERDs) to target hormone receptor positive breast cancer: elacestrant as the poster-child
ResearchIntegrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling
ResearchTRK inhibitor in a patient with metastatic triple-negative breast cancer and fusions identified by cell-free DNA analysis
ResearchCyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis
ResearchInterplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis
ResearchCirculating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer